David Chang
Directeur Technique/Scientifique/R&D chez CABALETTA BIO, INC.
Fortune : - $ au 30/04/2024
Profil
David J.
Chang is currently the Chief Medical Officer at Cabaletta Bio, Inc. Prior to this, he was the Senior Vice President and Head of Immuno-Inflammation and Neurosciences at AstraZeneca Pharmaceuticals LP from 2015 to 2019.
From 2007 to 2015, he was the Vice President and Head of Immuno-Inflammation at GSK Plc.
Dr. Chang received his doctorate degree from New York University School of Medicine, his graduate degree from Emory University, and his undergraduate degree from Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CABALETTA BIO, INC.
-.--% | 04/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de David Chang
| Sociétés | Poste | Début |
|---|---|---|
| CABALETTA BIO, INC. | Directeur Technique/Scientifique/R&D | 01/06/2019 |
Anciens postes connus de David Chang
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 01/05/2019 |
| GSK PLC | Corporate Officer/Principal | 01/06/2015 |
Formation de David Chang
| New York University School of Medicine | Doctorate Degree |
| Yale University | Undergraduate Degree |
| Emory University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CABALETTA BIO, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |